Carcinogenesis, Vol. 21, No. 8, 1567-1572,
August 2000
© 2000 Oxford University Press
Carcinogenesis |
Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis
Department of Pharmaceutical Sciences and
1 Department of Pathobiology, University of Connecticut, Storrs, CT 062692092, USA
Aberrant crypt foci (ACF), putative preneoplastic lesions, are early morphological changes induced by the colon carcinogen azoxymethane (AOM). Although inbred mice differ markedly in their susceptibility to AOM carcinogenesis, we have previously shown that ACF develop in both resistant and sensitive mouse strains after AOM treatment. The purpose of this study was to examine the sequential development and identify the morphological characteristics of ACF induced by AOM in the distal colon of sensitive and resistant mice. A/J (highly susceptible), SWR/J (relatively susceptible) and AKR/J (resistant) mice were treated with 10 mg/kg AOM or saline i.p. once a week for 6 weeks and were killed at 1, 2, 4, 6, 9 and 24 weeks after the last injection. The distal colons were stained with methylene blue and the numbers of ACF and tumors determined. Tumors were present as early as 4 weeks after AOM exposure in SWR/J and A/J mice and increased in frequency throughout the study in both strains. No tumors developed in the AKR/J mice. ACF, however, formed in all strains of mice. The greatest difference between susceptible and resistant strains was in the number of large ACF that developed at later time points. Furthermore, morphometric analysis revealed that A/J mice had the highest percentage of dysplastic ACF, followed by SWR/J mice. These data indicate that the difference in cancer risk from AOM may be due to the lack of progression of smaller ACF in the resistant mice and to the development of dysplasia in a higher percentage of ACF from susceptible strains.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. W. Rosenberg, C. Giardina, and T. Tanaka Mouse models for the study of colon carcinogenesis Carcinogenesis, February 1, 2009; 30(2): 183 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Femia, A. Giannini, M. Fazi, E. Tarquini, M. Salvadori, L. Roncucci, F. Tonelli, P. Dolara, and G. Caderni Identification of Mucin Depleted Foci in the Human Colon Cancer Prevention Research, December 1, 2008; 1(7): 562 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Halberg, M. C. Larsen, T. L. Elmergreen, A. Y. Ko, A. A. Irving, L. Clipson, and C. R. Jefcoate Cyp1b1 Exerts Opposing Effects on Intestinal Tumorigenesis via Exogenous and Endogenous Substrates Cancer Res., September 15, 2008; 68(18): 7394 - 7402. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Schweinfest, D. D. Spyropoulos, K. W. Henderson, J.-H. Kim, J. M. Chapman, S. Barone, R. T. Worrell, Z. Wang, and M. Soleimani slc26a3 (dra)-deficient Mice Display Chloride-losing Diarrhea, Enhanced Colonic Proliferation, and Distinct Up-regulation of Ion Transporters in the Colon J. Biol. Chem., December 8, 2006; 281(49): 37962 - 37971. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Derdak, P. Fulop, E. Sabo, R. Tavares, E. P. Berthiaume, M. B. Resnick, G. Paragh, J. R. Wands, and G. Baffy Enhanced colon tumor induction in uncoupling protein-2 deficient mice is associated with NF-{kappa}B activation and oxidative stress Carcinogenesis, May 1, 2006; 27(5): 956 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Suzuki, H. Kohno, S. Sugie, H. Nakagama, and T. Tanaka Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice Carcinogenesis, January 1, 2006; 27(1): 162 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N.M. Ilsley, M. Nakanishi, C. Flynn, G. S. Belinsky, S. De Guise, J. N. Adib, R. T. Dobrowsky, J. V. Bonventre, and D. W. Rosenberg Cytoplasmic Phospholipase A2 Deletion Enhances Colon Tumorigenesis Cancer Res., April 1, 2005; 65(7): 2636 - 2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W.L. Ma, R. H. Finnell, L. A. Davidson, E. S. Callaway, O. Spiegelstein, J. A. Piedrahita, J. M. Salbaum, C. Kappen, B. R. Weeks, J. James, et al. Folate Transport Gene Inactivation in Mice Increases Sensitivity to Colon Carcinogenesis Cancer Res., February 1, 2005; 65(3): 887 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Paulsen, E. M. Loberg, H. B. Olstorn, H. Knutsen, I.-L. Steffensen, and J. Alexander Flat Dysplastic Aberrant Crypt Foci Are Related to Tumorigenesis in the Colon of Azoxymethane-Treated Rat Cancer Res., January 1, 2005; 65(1): 121 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Nambiar, M. Nakanishi, R. Gupta, E. Cheung, A. Firouzi, X.-J. Ma, C. Flynn, M. Dong, K. Guda, J. Levine, et al. Genetic signatures of High- and Low-Risk Aberrant Crypt Foci in a Mouse Model of Sporadic Colon Cancer Cancer Res., September 15, 2004; 64(18): 6394 - 6401. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Caderni, A. P. Femia, A. Giannini, A. Favuzza, C. Luceri, M. Salvadori, and P. Dolara Identification of Mucin-depleted Foci in the Unsectioned Colon of Azoxymethane-treated Rats: Correlation with Carcinogenesis Cancer Res., May 15, 2003; 63(10): 2388 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hirose, T. Kuno, Y. Yamada, K. Sakata, M. Katayama, K. Yoshida, Z. Qiao, K. Hata, N. Yoshimi, and H. Mori Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis Carcinogenesis, January 1, 2003; 24(1): 107 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Erik Paulsen, I.-L. Steffensen, E. M. Loberg, T. Husoy, E. Namork, and J. Alexander Qualitative and Quantitative Relationship between Dysplastic Aberrant Crypt Foci and Tumorigenesis in the Min/+ Mouse Colon Cancer Res., July 1, 2001; 61(13): 5010 - 5015. [Abstract] [Full Text] [PDF] |
||||



